BIOSECURE Act gets update, gives US drugmakers until 2032 to sever ties with Chinese biotechs
Sanofi pays $80M to add Roche-rivaling Fulcrum drug to phase 3 rare disease pipeline
Takeda wagers up to $2.2bn on AC Immune Alzheimer’s shot
Merck stops testing combo drug for skin cancer as more patients discontinue
*please scroll down for all the latest news*
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud
Sanofi pays $80M to add Roche-rivaling Fulcrum drug to phase 3 rare disease pipeline
Takeda wagers up to $2.2bn on AC Immune Alzheimer’s shot
Merck stops testing combo drug for skin cancer as more patients discontinue
*please scroll down for all the latest news*
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud